Abiopharma

🔍 Baker Cary (Executive)

Company: IMPINJ INC (PI)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 1,739 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 89,965.00 | transaction_form_type: 4
• Sold 685 shares of Common Stock at $159.73 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 89,280.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,739 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,219.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs.
• F2: Each RSU represents a contingent right to receive one share of Impinj common stock.
• F3: On August 20, 2025, the reporting person was granted 6,958 RSUs. One-fourth of these vested on August 20, 2026.